Bolt Biotherapeutics Inc (NAS:BOLT)
$ 0.518 0.0077 (1.51%) Market Cap: 19.82 Mil Enterprise Value: -15.80 Mil PE Ratio: 0 PB Ratio: 0.28 GF Score: 40/100

Q1 2024 Bolt Biotherapeutics Inc Earnings Call Transcript

May 14, 2024 / 08:30PM GMT
Release Date Price: $1.32 (-0.75%)
Operator

Good afternoon and welcome to the Bolt biotherapeutics Strategic Update Conference Call. (Operator Instructions) As reminder, this call may be recorded.

I would now like to hand the call over to Willie Quinn, Chief Executive Officer of both both biotherapeutics. Please go ahead, sir.

Willie Quinn
Bolt Biotherapeutics Inc - Chief Executive Officer

Thank you, and good afternoon, everyone. This afternoon, we issued our first quarter 2024 financial results and business update, which outlines the topics we plan to discuss today. You can access the press release by going to the Investors and Media section of our website at www.boltbio.com.

I am joined today by Randy Schatzman, outgoing Chief Executive Officer, and Edith Perez outgoing Chief Medical Officer. I am also joined by some newly promoted members of both senior leadership team, including Michael Alonso, so Co-Founder of Bolt and newly promoted Senior Vice President of Research, and Dawn Colburn, newly promoted Senior Vice

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot